EGFR and neoplasm: At the same time, there was a clear trend for all mutated tumor samples collectively to show a colder phenotype compared to EGFR/ERBB2wt group (P = 0.068), the majority of which could be assigned to the immunological group of ‘hot’ tumors (17/26 = 65% versus 9/26 = 35%).